Trinity Biotech reported $11.51M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Bayer BAYN:GR € 5680M 504M
Bio Rad Laboratories BIO:US $ 295.12M 1.38M
Edap Tms EDAP:US $ 8.33M 0.32M
Johnson & Johnson JNJ:US $ 7919M 321M
Mesa Laboratories MLAB:US $ 19.11M 4.66M
Orasure Technologies OSUR:US $ 52.65M 9.21M
Siemens SIE:GR € 11638M 339M
Sientra SIEN:US $ 8.77M 218K
Surmodics SRDX:US $ 5.14M 0.03M
Thermo Fisher Scientific TMO:US $ 6240M 114M
Tosoh 4042:JP 187.47B 10.29B
Trinity Biotech TRIB:US $ 11.51M 0.78M
Veracyte VCYT:US $ 25.03M 1.32M